Design of Hybrid Molecules for Drug Development
by Michael Decker (Editor)
Design of Hybrid Molecules for Drug Development – A Cutting-Edge Approach to Drug Design
Design of Hybrid Molecules for Drug Development by Michael Decker offers a fresh and innovative approach to drug design and development. This book explores the principles, advantages, and limitations of designing hybrid molecules for drug development. With practical case studies, the author showcases the potential of hybrid molecules in treating a range of diseases, including Alzheimer’s, cancer, and malaria.
Overview of Hybrid Molecule Design
The book begins with an introduction to hybrid molecule design and the need for this groundbreaking approach in drug development. By combining different molecular components, hybrid molecules offer unique properties that traditional drug molecules lack. This approach allows researchers to overcome the limitations of classical lead structure searches, a key problem in modern drug development.
The author then delves into a range of important hybrids, including those containing natural products, molecules containing NO- and H2S-donors, dual-acting compounds acting as receptor ligands and enzyme inhibitors, and the design of photoresponsive drugs. Through detailed explanations and examples, Decker demonstrates the advantages and limitations of each type of hybrid molecule.
Practical Case Studies
The book draws on practical case studies to showcase the application of hybrid molecule design in real-world scenarios. Decker explores the hybridization of molecules for the development of treatments for various diseases, such as Alzheimer’s, cancer, and malaria.
By providing insights into the design process and showcasing successful applications, the book equips researchers and drug developers with the knowledge and tools necessary to harness the potential of hybrid molecules for efficient and effective drug development.
Breaking Developments and Future Directions
The book also covers the latest advancements in hybrid molecule design, including the development of photoactivatable and photoresponsive drugs. These cutting-edge developments pave the way for novel drug therapies that can be activated or controlled by light, offering new possibilities for targeted treatments.
Furthermore, the author discusses future directions in hybrid molecule design and highlights emerging trends and technologies that may shape the field. This provides readers with a glimpse into what lies ahead and the opportunities that hybrid molecules may offer for the development of next-generation drugs.
Why Choose Design of Hybrid Molecules for Drug Development?
Design of Hybrid Molecules for Drug Development stands out from other books in the field due to its comprehensive coverage of hybrid molecule design principles and practical applications. The book offers:
- – A novel approach to drug design that overcomes the limitations of traditional lead structure searches
- – Detailed case studies to illustrate the potential of hybrid molecules in treating various diseases
- – Comparison of the advantages and disadvantages of different types of hybrid molecules
- – Exploration of cutting-edge developments, including photoactivatable and photoresponsive drugs
Design of Hybrid Molecules for Drug Development is an essential resource for researchers, drug developers, and anyone involved in the design, development, and administration of drugs for debilitating disorders. The book provides valuable insights, techniques, and guidance to enhance the drug development process and drive innovation in the field.
Order Your Copy Today
If you are interested in exploring the potential of hybrid molecules for drug development, don’t miss out on Design of Hybrid Molecules for Drug Development. Order your copy now and discover the cutting-edge approach to drug design that is revolutionizing the field.
Product Details
- Highlights an approach unimpaired by the limitations of the classical search for lead structures – one of the core problems in modern drug development processes, making the content of high relevance for both academic and non-academic drug development processes
- Pulls together research and design techniques in a novel way to give researchers the best possible platform from which to review the approaches and techniques applied
- Compares the advantages and disadvantages of these compounds
- Includes the very latest developments, such as photoactivatable and photo-responsive drugs
- : 352 pages
- Publisher: Elsevier; 1 edition (April 25, 2017)
- Language: English
- ISBN-10: 0081010117
- ISBN-13: 978-0081010112
- Product Dimensions: 7.5 x 0.8 x 9.2 inches